title: Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany.
abstract: Besides typing and grading of breast cancer, Pathologists are involved in the determination of biomarkers, such as steroid hormone receptors and HER2, which are of utmost importance in adjuvant therapy. There have been concerns with regard to security and reproducibility of the biomarker assays done on tissue sections applying either immunohistochemistry or in-situ hybridisation. In order to assure the quality of these biomarker assays, a number of measures are required, among them external proficiency testing. Therefore, external quality assurance trials have been implemented in Germany. In the period of 2002-2007, 5 consecutive trials were conducted with up to 180 participating laboratories. Tissue microarrays with 20-24 different breast cancer samples including cell lines enabled that a huge number of pathologists were challenged with identical samples which provides the prerequisite for comparability. Because there is no legal duress to undergo external proficiency testing in histopathology, all laboratories that took part volunteered to do so. These innovative quality assurance trials (Qualitätsinitiative Pathologie, QuIP) will be continued in the future on an annual or bi-annual basis. Participation is recommended for pathology departments involved in the service for breast units. The organisational frame work of the trials is described here.
authors.affiliation: Institut für Pathologie, Medizinische Hochschule Hannover, Germany.
authors.forename: Reinhard
authors.initials: R
authors.lastname: von Wasielewski
authors.forename: Claudia A
authors.initials: CA
authors.lastname: Krusche
authors.forename: Joseph
authors.initials: J
authors.lastname: Rüschoff
authors.forename: Anette
authors.initials: A
authors.lastname: Fisseler-Eckhoff
authors.forename: Hans
authors.initials: H
authors.lastname: Kreipe